A 58-year-old with long-standing type 2 diabetes and CKD starts an SGLT2 inhibitor. What early change is expected and acceptable?...

Question

A 58-year-old with long-standing type 2 diabetes and CKD starts an SGLT2 inhibitor. What early change is expected and acceptable?

Accepted Answer

Initial small dip in eGFR (

Answer

Sustained rise in eGFR by 30%

Answer

Hyperkalemia requiring discontinuation

Answer

Severe DKA in all patients

Answer

Hyponatremia universally

us-abim MCQ (SBA): SGLT2 Physiology in CKD